PapersFlow Research Brief
Cannabis and Cannabinoid Research
Research Guide
What is Cannabis and Cannabinoid Research?
Cannabis and Cannabinoid Research is the scientific study of the endocannabinoid system, cannabinoid receptors, health effects of cannabis use, and therapeutic applications of cannabinoids in neurological, psychiatric, and metabolic disorders.
This field encompasses 88,400 works examining synaptic transmission, neuroprotection, and medical marijuana. Researchers have identified key components such as anandamide as an endogenous ligand for cannabinoid receptors. Studies demonstrate the roles of CB1 and CB2 receptors in mediating physiological responses including analgesia and reinforcement.
Topic Hierarchy
Research Sub-Topics
Endocannabinoid System Signaling
This sub-topic investigates the biosynthesis, release, uptake, and degradation of endocannabinoids like anandamide and 2-AG, along with their signaling through CB1 and CB2 receptors. Researchers study regulatory enzymes such as FAAH and MAGL.
Cannabinoid Receptors Structure
Researchers employ cryo-EM and X-ray crystallography to determine CB1 and CB2 receptor structures, ligand binding sites, and G-protein coupling mechanisms. This includes allosteric modulators and biased agonism studies.
Cannabis Neuroprotection
This area examines how cannabinoids protect neurons from excitotoxicity, ischemia, and oxidative stress in models of stroke, traumatic brain injury, and neurodegeneration. Studies explore anti-inflammatory and antioxidant pathways.
Cannabinoids Psychiatric Effects
Research assesses cannabis use impacts on mood, anxiety, psychosis risk, and addiction vulnerability, using epidemiological cohorts and neuroimaging. Focus includes adolescent brain development and schizophrenia associations.
Medical Marijuana Metabolic Disorders
This sub-topic studies cannabinoid modulation of obesity, diabetes, and dyslipidemia via peripheral CB1 receptors and gut microbiome interactions. Clinical trials evaluate THC/CBD effects on insulin sensitivity and appetite.
Why It Matters
Cannabis and Cannabinoid Research informs treatments for neurological and psychiatric disorders through insights into the endocannabinoid system. Devane et al. (1992) isolated arachidonylethanolamide, named anandamide, from porcine brain as an endogenous cannabinoid receptor ligand, enabling studies on natural signaling pathways. Munro et al. (1993) characterized a peripheral cannabinoid receptor, now known as CB2, which influences immune responses and inflammation. Matsuda et al. (1990) cloned the CB1 receptor cDNA, facilitating genetic investigations into its expression in the brain. Ledent et al. (1999) generated CB1 receptor knockout mice that showed no response to cannabinoids and reduced opiate addictive effects, highlighting CB1's role in drug reinforcement and supporting targeted therapies for addiction and pain.
Reading Guide
Where to Start
"Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor" (1992) by Devane et al., as it introduces anandamide, the first endogenous cannabinoid, providing essential background on natural ligands before receptor studies.
Key Papers Explained
Matsuda et al. (1990) in "Structure of a cannabinoid receptor and functional expression of the cloned cDNA" first cloned the central CB1 receptor. Devane et al. (1992) in "Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor" identified anandamide as its endogenous ligand. Munro et al. (1993) in "Molecular characterization of a peripheral receptor for cannabinoids" characterized the CB2 receptor, expanding the system. Ledent et al. (1999) in "Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice" used CB1 knockouts to confirm receptor functions, building on prior molecular work.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues on CB1 and CB2 receptor signaling in synaptic transmission and neuroprotection, with applications to neurological disorders. No recent preprints or news available; foundational papers like those on knockouts guide ongoing genetic and pharmacological studies.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Autophagy fights disease through cellular self-digestion | 2008 | Nature | 6.4K | ✓ |
| 2 | Autophagy: Renovation of Cells and Tissues | 2011 | Cell | 6.2K | ✓ |
| 3 | Isolation and Structure of a Brain Constituent That Binds to t... | 1992 | Science | 5.6K | ✕ |
| 4 | Molecular characterization of a peripheral receptor for cannab... | 1993 | Nature | 5.0K | ✕ |
| 5 | Structure of a cannabinoid receptor and functional expression ... | 1990 | Nature | 5.0K | ✕ |
| 6 | Methods in Mammalian Autophagy Research | 2010 | Cell | 4.4K | ✓ |
| 7 | Autophagy: process and function | 2007 | Genes & Development | 3.9K | ✓ |
| 8 | Development by Self-Digestion | 2004 | Developmental Cell | 3.6K | ✓ |
| 9 | Unresponsiveness to Cannabinoids and Reduced Addictive Effects... | 1999 | Science | 3.6K | ✕ |
| 10 | Autophagy and the Integrated Stress Response | 2010 | Molecular Cell | 3.4K | ✓ |
Frequently Asked Questions
What is anandamide?
Anandamide is arachidonylethanolamide, an arachidonic acid derivative identified in porcine brain as an endogenous ligand for the cannabinoid receptor. "Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor" (1992) determined its structure using mass spectrometry and nuclear magnetic resonance spectroscopy. This compound binds to cannabinoid receptors in the endocannabinoid system.
What is the CB1 receptor?
The CB1 receptor is a central cannabinoid receptor cloned and functionally expressed from its cDNA. "Structure of a cannabinoid receptor and functional expression of the cloned cDNA" (1990) by Matsuda et al. detailed its molecular structure and expression. CB1 mediates effects such as analgesia, reinforcement, and hypothermia.
What is the CB2 receptor?
The CB2 receptor is a peripheral cannabinoid receptor molecularly characterized in non-neuronal tissues. "Molecular characterization of a peripheral receptor for cannabinoids" (1993) by Munro et al. identified its sequence and distribution. It plays roles in immune modulation and inflammation.
How does CB1 knockout affect cannabinoid responses?
CB1 receptor knockout mice show no response to cannabinoid drugs, confirming CB1's exclusive mediation of analgesia, reinforcement, hypothermia, hypolocomotion, and hypotension. "Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice" (1999) by Ledent et al. also found reduced acute addictive effects of opiates. These mutants demonstrate CB1's central role in cannabinoid pharmacology.
What topics does Cannabis and Cannabinoid Research cover?
The field covers the endocannabinoid system, cannabinoid receptors, cannabis use effects on health, and therapeutic applications in neurological, psychiatric, and metabolic disorders. Key areas include synaptic transmission, neuroprotection, medical marijuana, CB1 and CB2 receptors. It totals 88,400 works focused on these mechanisms.
Why study cannabinoid receptors?
Cannabinoid receptors like CB1 and CB2 underpin the endocannabinoid system's regulation of physiological processes. Papers such as "Structure of a cannabinoid receptor and functional expression of the cloned cDNA" (1990) and "Molecular characterization of a peripheral receptor for cannabinoids" (1993) provide foundational molecular data. This knowledge supports cannabinoid-based therapies for pain, addiction, and disorders.
Open Research Questions
- ? How do endogenous cannabinoids like anandamide interact with CB1 and CB2 receptors at the synaptic level?
- ? What are the long-term neurological impacts of chronic cannabis use mediated by CB1 receptors?
- ? Can CB2 receptor modulation treat metabolic disorders without psychoactive effects?
- ? How does the endocannabinoid system influence psychiatric disorders beyond reinforcement pathways?
- ? What structural features of cannabinoid receptors enable selective ligand binding?
Recent Trends
The field comprises 88,400 works with no specified 5-year growth rate available.
High-citation papers from 1990-1999, such as Devane et al. with 5599 citations and Ledent et al. (1999) with 3606 citations, remain central.
1992No recent preprints or news coverage in the last 12 months or 6 months reported.
Research Cannabis and Cannabinoid Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cannabis and Cannabinoid Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers